<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2025-15-2-97-103</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-1092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Этаноловая склеротерапия с радиочастотной абляцией в лечении токсической аденомы (клинический случай)</article-title><trans-title-group xml:lang="en"><trans-title>Ethanol Sclerotherapy Combined with Radiofrequency Ablation in the Treatment of Toxic Adenoma: Clinical Case</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1905-6904</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гумерова</surname><given-names>Г. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Gumerova</surname><given-names>G. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гумерова Гульнара Тагировна — к.м.н, доцент, кафедра общей хирургии с курсами трансплантологии и лучевой диагностики</p><p>Республика Башкортостан, Уфа </p></bio><bio xml:lang="en"><p>Gulnara T. Gumerova — Cand. Sci. (Med.), Assoc. Prof., Department of General Surgery with Transplantology and Radiodiagnosis courses</p><p>Ufa </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1710-8045</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарьин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макарьин Виктор Алексеевич — к.м.н., хирургическое отделение № 2</p><p>Гатчина </p></bio><bio xml:lang="en"><p>Viktor A. Makarin — Cand. Sci. (Med.), Surgery Unit No. 2</p><p>Ufa </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-4605-0997</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тушова</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Tushova</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тушова Айгуль Фанилевна — к.м.н.</p><p>Республика Башкортостан, Уфа </p></bio><bio xml:lang="en"><p>Aigul F. Tushova — Cand. Sci. (Med.)</p><p>Ufa </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-6873-7585</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фазлыева</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Fazlyeva</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фазлыева Алия Фанисовна  </p><p>Республика Башкортостан, Уфа </p></bio><bio xml:lang="en"><p>Aliya F. Fazlyeva  </p><p>Ufa </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-9943-2351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ишбулатова</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ishbulatova</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ишбулатова Алия Исинтимировна  </p><p>Республика Башкортостан, Уфа </p></bio><bio xml:lang="en"><p>Aliya I. Ishbulatova </p><p>Ufa </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-7878-1731</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Климец</surname><given-names>С. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimets</surname><given-names>S. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Климец Софья Павловна  </p><p>Республика Башкортостан, Уфа </p></bio><bio xml:lang="en"><p>Sofya P. Klimets  </p><p>Ufa </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8129-0665</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Надеждина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nadezhdina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Надеждина Екатерина Андреевна — студентка 6-го курса, педиатрический факультет</p><p>Республика Башкортостан, Уфа </p></bio><bio xml:lang="en"><p>Ekaterina A. Nadezhdina — Graduate Student (6th year), Faculty of Pediatrics</p><p>Ufa </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-8246-3699</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Неряхин</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Neryakhin</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Неряхин Александр Дмитриевич — студент 5-го курса, педиатрический факультет</p><p>Республика Башкортостан, Уфа </p></bio><bio xml:lang="en"><p>Alexander D. Neryakhin — 5th year Student, Faculty of Pediatrics</p><p>Ufa </p></bio><email xlink:type="simple">nereahins@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Башкирский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Гатчинская клиническая межрайонная больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Gatchina Clinical Interdistrict Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Клиника регионарной эндокринологии, диагностики и образования «КРЭДО»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinic of regional endocrinology, diagnostics and education “KREDO”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>01</day><month>07</month><year>2025</year></pub-date><volume>15</volume><issue>2</issue><fpage>193</fpage><lpage>199</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гумерова Г.Т., Макарьин В.А., Тушова А.Ф., Фазлыева А.Ф., Ишбулатова А.И., Климец С.П., Надеждина Е.А., Неряхин А.Д., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Гумерова Г.Т., Макарьин В.А., Тушова А.Ф., Фазлыева А.Ф., Ишбулатова А.И., Климец С.П., Надеждина Е.А., Неряхин А.Д.</copyright-holder><copyright-holder xml:lang="en">Gumerova G.T., Makarin V.A., Tushova A.F., Fazlyeva A.F., Ishbulatova A.I., Klimets S.P., Nadezhdina E.A., Neryakhin A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/1092">https://www.surgonco.ru/jour/article/view/1092</self-uri><abstract><p>Введение. Тиреотоксические состояния обусловлены гиперпродукцией гормонов щитовидной железы. Согласно данным статистики на территории Российской Федерации выявлен рост случаев тиреотоксикоза, в 2018 году зафиксировано 132 на 100 тыс. населения. Диффузный токсический зоб является одним из наиболее часто встречаемых в структуре патологий, сопровождающихся тиреотоксикозом. Гипертиреоз может быть обусловлен также токсическими аденомами щитовидной железы. Встречаются поражения одной доли, с солитарным узлом, и множественные узловые образования как одной доли, так и обеих долей, относящиеся к токсическому многоузловому зобу. При описании клинических проявлений аденом выделяют следующие симптомы: местные, в виде косметических проблем, и тиреотоксикоз, которые определяют тактику дальнейшего ведения. Цель. Развитие персонализированных малоинвазивных подходов к лечению новообразований щитовидной железы обусловлено необходимостью сохранения объема функционирующей ткани органа. Материалы и методы. В статье изложен клинический случай лечения пациента с узловым зобом и признаками тиреотоксикоза. Проведено хирургическое лечение разработанным группой авторов комбинированным методом, включающим поэтапную подготовку этаноловой склеротерапией с последующей радиочастотной абляцией узла. Результаты и обсуждение. Продемонстрировано последствие малоинвазивной операции на щитовидной железе в виде нормализации гормонального фона, уменьшения узлового образования в 7 раз, улучшения качества жизни и восстановления естественных контуров шеи. Заключение. Описаны перспективы применения интервенционной эндокринной хирургии с возможностью органосохраняющего вмешательства у пациентов с токсическими узловыми образованиями.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Thyrotoxic states are the result of an overproduction of thyroid hormones. Statistics from Russia indicate an increasing incidence of thyrotoxicosis, with 132 cases documented per 100,000 population in 2018. Diffuse toxic goiter is among the most frequent pathologies associated with thyrotoxic conditions. Hyperthyroidism can also result from toxic thyroid adenomas. Toxic nodular goiter is a condition that can manifest in various ways, including single lobe involvement with a solitary nodule or multiple nodules within one or both lobes. The clinical features of these adenomas encompass local symptoms, including cosmetic concerns, and systemic thyrotoxicosis, which inform subsequent management strategies. Aim. The development of personalized, minimally invasive approaches for treating thyroid neoplasms is driven by the need to preserve functioning organ tissue. Materials and methods. This article details a clinical case involving a patient diagnosed with nodular goiter exhibiting signs of thyrotoxicosis. We developed a combined surgical intervention, involving staged ethanol sclerotherapy followed by radiofrequency ablation of the nodule. Results and discussion. The minimally invasive thyroid intervention resulted in the normalization of hormonal balance, a 7-fold reduction in nodule size, an improvement in quality of life, and the restoration of natural neck contours. Conclusion. The study highlights the potential of interventional endocrine surgery as a means of preserving organ function in patients with toxic nodular formations.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>токсическая аденома</kwd><kwd>узловой зоб</kwd><kwd>тиреотоксикоз</kwd><kwd>чрескожная инъекция этанола</kwd><kwd>склеротерапия</kwd><kwd>радиочастотная абляция</kwd><kwd>интервенционная хирургия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>toxic adenoma</kwd><kwd>nodular goiter</kwd><kwd>thyrotoxicosis</kwd><kwd>percutaneous ethanol injection</kwd><kwd>sclerotherapy</kwd><kwd>radiofrequency ablation</kwd><kwd>interventional surgery</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Трошина Е.А., Платонова Н.М., Панфилова Е.А. Аналитический обзор результатов мониторинга основных эпидемиологических характеристик йододефицитных заболеваний у населения Российской Федерации за период 2009–2018 гг. Проблемы эндокринологии. 2021;67(2):10–9. DOI: 10.14341/probl12433</mixed-citation><mixed-citation xml:lang="en">Troshina E.A., Platonova N.M., Panfilova E.A. Dynamics of epidemiological indicators of thyroid pathology in the population of the Russian Federation: analytical report for the period 2009–2018. Problems of Endocrinology. 2021;67(2):10–9 (In Russ.). DOI: 10.14341/probl12433</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chaker L., Cooper D.S., Walsh J.P., Peeters R.P. Hyperthyroidism. Lancet. 2024;403(10428):768–80. DOI: 10.1016/S0140-6736(23)02016-0</mixed-citation><mixed-citation xml:lang="en">Chaker L., Cooper D.S., Walsh J.P., Peeters R.P. Hyperthyroidism. Lancet. 2024;403(10428):768–80. DOI: 10.1016/S0140-6736(23)02016-0</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Doubleday A.R., Sippel R.S. Hyperthyroidism. Gland Surg. 2020;9(1):124–35. DOI: 10.21037/gs.2019.11.01</mixed-citation><mixed-citation xml:lang="en">Doubleday A.R., Sippel R.S. Hyperthyroidism. Gland Surg. 2020;9(1):124–35. DOI: 10.21037/gs.2019.11.01</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Пашенцева А.В., Вербовой А.Ф. Диффузный токсический зоб. Клиническая медицина. 2017; 95(9):780–8. DOI: 10.18821/0023-2149-2017-95-9-780-788</mixed-citation><mixed-citation xml:lang="en">Pashentseva A.V., Verbovoy A.F. Diffuse toxic goiter. Klin. med. 2017;95(9):780–8 (In Russ.). DOI: 10.18821/0023-2149-2017-95-9-780-788</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mulita F., Anjum F. Thyroid adenoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562252/</mixed-citation><mixed-citation xml:lang="en">Mulita F., Anjum F. Thyroid adenoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562252/</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">do Prado Padovani R., Chablani S.V., Tuttle R.M. Radioactive iodine therapy: multiple faces of the same polyhedron. Arch Endocrinol Metab. 2022 May 13;66(3):393–406. DOI: 10.20945/2359-3997000000461</mixed-citation><mixed-citation xml:lang="en">do Prado Padovani R., Chablani S.V., Tuttle R.M. Radioactive iodine therapy: multiple faces of the same polyhedron. Arch Endocrinol Metab. 2022 May 13;66(3):393–406. DOI: 10.20945/2359-3997000000461</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Гумерова Г.Т., Неряхин А.Д., Асфандиярова И.В., Ишбулатова А.И., Фазлыева А.Ф., Климец С.П. и др. Способ двухэтапного лечения узлового токсического зоба: патент 2820877, Российская Федерация. 16.11.2023.</mixed-citation><mixed-citation xml:lang="en">Gumerova G.T., Neryahin A.D., Asfandiyarova I.V., Ishbulatova A.I., Fazlyeva A.F., Klimec S.P., et al. Method for two-stage treatment of nodular toxic goiter: Russian Federation, patent 2820877. 2023 November 16 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shahid M., Cetera B. Thyroid disease and thyroid surgery. Anaesth Intens Care Med. 2023;24:594–607. DOI: 10.1016/j.mpaic.2023.07.009</mixed-citation><mixed-citation xml:lang="en">Shahid M., Cetera B. Thyroid disease and thyroid surgery. Anaesth Intens Care Med. 2023;24:594–607. DOI: 10.1016/j.mpaic.2023.07.009</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary Thyroid Nodule Evaluation and Management. J Clin Endocrinol Metab. 2020 Sep 1;105(9):2869–83. DOI: 10.1210/clinem/dgaa322</mixed-citation><mixed-citation xml:lang="en">Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary Thyroid Nodule Evaluation and Management. J Clin Endocrinol Metab. 2020 Sep 1;105(9):2869–83. DOI: 10.1210/clinem/dgaa322</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sjölin G., Watt T., Byström K., Calissendorff J., Cramon P.K., Nyström H.F., et al. Long term outcome after toxic nodular goitre. Thyroid Res. 2022;15(1):20. DOI: 10.1186/s13044-022-00138-0</mixed-citation><mixed-citation xml:lang="en">Sjölin G., Watt T., Byström K., Calissendorff J., Cramon P.K., Nyström H.F., et al. Long term outcome after toxic nodular goitre. Thyroid Res. 2022;15(1):20. DOI: 10.1186/s13044-022-00138-0</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S.Q., Gou R.Q., Zhang Q. The evolution and hotspots of radioactive iodine therapy in hyperthyroidism: a bibliometric analysis. Nucl Med Commun. 2025;46(3):204–17. DOI: 10.1097/MNM.0000000000001940</mixed-citation><mixed-citation xml:lang="en">Chen S.Q., Gou R.Q., Zhang Q. The evolution and hotspots of radioactive iodine therapy in hyperthyroidism: a bibliometric analysis. Nucl Med Commun. 2025;46(3):204–17. DOI: 10.1097/MNM.0000000000001940</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bonnema S.J., Hegedüs L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocrine Rev. 2012;33:920–80. DOI: 10.1210/er.2012-1030</mixed-citation><mixed-citation xml:lang="en">Bonnema S.J., Hegedüs L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocrine Rev. 2012;33:920–80. DOI: 10.1210/er.2012-1030</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Riley A.S., McKenzie G.A.G., Green V., Schettino G., England R.J.A., Greenman J. The effect of radioiodine treatment on the diseased thyroid gland. Int J Radiat Biol. 2019;95(12):1718–27. DOI: 10.1080/09553002.2019.1665206</mixed-citation><mixed-citation xml:lang="en">Riley A.S., McKenzie G.A.G., Green V., Schettino G., England R.J.A., Greenman J. The effect of radioiodine treatment on the diseased thyroid gland. Int J Radiat Biol. 2019;95(12):1718–27. DOI: 10.1080/09553002.2019.1665206</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Donovan P.J., McLeod D.S., Little R., Gordon L. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves’ disease. Eur J Endocrinol. 2016;175(6):595–603. DOI: 10.1530/EJE-16-0527</mixed-citation><mixed-citation xml:lang="en">Donovan P.J., McLeod D.S., Little R., Gordon L. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves’ disease. Eur J Endocrinol. 2016;175(6):595–603. DOI: 10.1530/EJE-16-0527</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Papini E., Pacella C.M., Misischi I., Guglielmi R., Bizzarri G., Døssing H., et al. The advent of ultrasound-guided ablation techniques in nodular thyroid disease: towards a patient-tailored approach. Best Pract Res Clin Endocrinol Metab. 2014;28(4):601–18. DOI: 10.1016/j.beem.2014.02.004</mixed-citation><mixed-citation xml:lang="en">Papini E., Pacella C.M., Misischi I., Guglielmi R., Bizzarri G., Døssing H., et al. The advent of ultrasound-guided ablation techniques in nodular thyroid disease: towards a patient-tailored approach. Best Pract Res Clin Endocrinol Metab. 2014;28(4):601–18. DOI: 10.1016/j.beem.2014.02.004</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Muhammad H., Tehreem A., Russell J.O., Tufano R.P. Radiofrequency ablation and autonomous functioning thyroid nodules: review of the current literature. Laryngoscope. 2022;132(4):906–14. DOI: 10.1002/lary.29811</mixed-citation><mixed-citation xml:lang="en">Muhammad H., Tehreem A., Russell J.O., Tufano R.P. Radiofrequency ablation and autonomous functioning thyroid nodules: review of the current literature. Laryngoscope. 2022;132(4):906–14. DOI:10.1002/lary.29811</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Podrat J.L., Lee Y.K., Khadra H.S. Efficacy of radiofrequency ablation for treatment of toxic thyroid nodules-a narrative review. Gland Surg. 2024;13(1):70–6. DOI: 10.21037/gs-22-644</mixed-citation><mixed-citation xml:lang="en">Podrat J.L., Lee Y.K., Khadra H.S. Efficacy of radiofrequency ablation for treatment of toxic thyroid nodules-a narrative review. Gland Surg. 2024;13(1):70–6. DOI: 10.21037/gs-22-644</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
